Gynecologic Oncology

Aims & Scope

Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract.

Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.

Research Areas Include: • Cell and molecular biology • Chemotherapy • Cytology • Endocrinology • Epidemiology • Genetics • Gynecologic surgery • Immunology • Pathology • Radiotherapy

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.1
2024	4.50

Journal Rank

Year	Value
2024	1614

Journal Citation Indicator

Year	Value
2024	4599

SJR (SCImago Journal Rank)

Year	Value
2024	1.881

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	192

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Two pathogenetic types of endometrial carcinoma

  Citation: 2002

  Authors: Jan V.

• RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

  Citation: 1931

  Authors: Douglas D., Cicek

• A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

  Citation: 1397

  Authors: Henry M, James A, Virginia L, Richard J, Nick M, Jeffrey D, Andrew, Mitchell A, Jeffrey G

• A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study

  Citation: 1087

  Authors: Alexander, Brian N., Marvin Z., Samuel S., Laila I., Richard J.

• Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

  Citation: 1083

  Authors: C.Paul, Brian N., Robert J., William T., Paul, Howard D., James E.

• Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

  Citation: 762

  Authors: Gregorio, Brian, Richard, Bernd-Uwe, William T., Francis

• A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

  Citation: 687

  Authors: Richard G., D. Scott, Amy K., Paul, M. Craig, W. Jeffrey, Walter, Robert, Robert C., Steven J.

• Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging

  Citation: 681

  Authors: Andrea, Sean C., William A., Bobbie S., Monica B., Timothy O., Karl C.

• Uterine sarcomas: A review

  Citation: 605

  Authors: Emanuela, Jaime

• The Rising Incidence of Adenocarcinoma Relative to Squamous Cell Carcinoma of the Uterine Cervix in the United States—A 24-Year Population-Based Study

  Citation: 576

  Authors: Harriet O., Michael F., Clifford R., Charles R.

---